Current Net Margin
—
Allogene Therapeutics, Inc. currently has a net profit margin of —.
Financial Fundamentals
ALLO • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.04 | — | — |
| 2025-09-30 | 0.00 | -0.04 | — | — |
| 2025-06-30 | 0.00 | -0.05 | — | — |
| 2025-03-31 | 0.00 | -0.06 | — | — |
| 2024-12-31 | 0.00 | -0.06 | — | — |
| 2024-09-30 | 0.00 | -0.07 | — | — |
| 2024-06-30 | 0.00 | -0.07 | — | — |
| 2024-03-31 | 0.00 | -0.07 | -295454.55% | ▼49831136 |
| 2023-12-31 | -0.00 | -0.09 | 202856.82% | ▲48597955 |
| 2023-09-30 | 0.00 | -0.06 | -283122.73% | ▲7702273 |
| 2023-06-30 | 0.00 | -0.08 | -360145.45% | ▼2691879 |
| 2023-03-31 | 0.00 | -0.10 | -333226.67% | ▼13142454 |
| 2022-12-31 | 0.00 | -0.09 | -201802.13% | ▼3211233 |
| 2022-09-30 | 0.00 | -0.08 | -169689.80% | ▼8272817 |
| 2022-06-30 | 0.00 | -0.07 | -86961.63% | ▲4394001 |
| 2022-03-31 | 0.00 | -0.08 | -130901.64% | ▲1589836 |
| 2021-12-31 | 0.00 | -0.07 | -146800.00% | ▲1276327 |
| 2021-09-30 | 0.00 | -0.08 | -159563.27% | ▲165492 |
| 2021-06-30 | 0.00 | -0.07 | -161218.18% | ▼16113208 |
| 2021-03-31 | 0.04 | -0.03 | -86.10% | — |
| 2020-12-31 | 0.00 | -0.07 | — | — |
| 2020-09-30 | 0.00 | -0.07 | — | — |
| 2020-06-30 | 0.00 | -0.06 | — | — |
| 2020-03-31 | 0.00 | -0.05 | — | — |
| 2019-12-31 | 0.00 | -0.06 | — | — |
| 2019-09-30 | 0.00 | -0.05 | — | — |
| 2019-06-30 | 0.00 | -0.04 | — | — |
| 2019-03-31 | 0.00 | -0.03 | — | — |
| 2018-12-31 | 0.00 | -0.03 | — | — |
| 2018-09-30 | 0.00 | -0.04 | — | — |
| 2018-06-30 | 0.00 | -0.13 | — | — |
| 2018-03-31 | 0.00 | -0.00 | — | — |
| 2017-12-31 | 0.00 | -0.00 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.